Masimo (MASI)
(Delayed Data from NSDQ)
$135.69 USD
+1.84 (1.37%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $135.63 -0.06 (-0.04%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth F Momentum D VGM
Brokerage Reports
Masimo Corporation [MASI]
Reports for Purchase
Showing records 161 - 180 ( 484 total )
Company: Masimo Corporation
Industry: Medical - Instruments
Wedbush Best Ideas List Update.
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Investor Day Highlights the Drivers to MASI''s Robust Growth Targets; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
Investor Day Details Attractive Long-Term Outlook
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Masimo Corporation
Industry: Medical - Instruments
Investor Day Highlights the Drivers to MASI''s Robust Growth Targets; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Masimo Corporation
Industry: Medical - Instruments
Solid Quarter Provides Perfect Segue To Next Week''s Investor Day; Raising PT to $112; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
1Q Tops Expectations on Continued Strong Core SET Growth
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Masimo Corporation
Industry: Medical - Instruments
Discontinuation of Research Coverage
Provider: Feltl & Company
Company: Masimo Corporation
Industry: Medical - Instruments
Best Ideas List: Update
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
1Q17 Preview: Outperforming in MedTech Year-to-Date Reflects Stable Fundamentals That Should Continue Throughout 2017
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
Raising Near- and Long-term Estimates to Reflect Flu and New Product Categories; Increasing PT to $100 and Reiterating OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Best Ideas List: Update
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
Company: Masimo Corporation
Industry: Medical - Instruments
Flu Season Remains Elevated, Bodes Well for MASI''s 1Q17 Results; Raising PT to $95; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Masimo Corporation
Industry: Medical - Instruments
Best Ideas List: Update
Provider: WEDBUSH SECURITIES INC.